Treatment of patients with moderate to severe Alzheimer’s disease.
MEMANTINE HYDROCHLORIDE — ZYDUS LIFESCIENCES, approved 2019-06-28 (ANDA090961).
9,353 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.